Table 3.
Comparison of disease activity score (mean ±SD)
MTX + HCQ (Min.-Max.) | LEF (Min.-Max.) | P | |
---|---|---|---|
Baseline | 6.42 ± 1.74 (VA) (1–8) | 6.91 ± 1.19 (VA) (3–7) | 0.453 |
Sixth week | 5.00 ± 1.61 (MA) (1–8) | 5.30 ± 1.28 (MA) (3–7) | 0.601 |
Twelfth week | 3.37 ± 0.84 (MA) (1–5) | 3.61 ± 0.63 (MA) (2–5) | 0.266 |
P | <0.001* | <0.001* |
Disease activity: VA, very active; MA, moderate active;
Statistically significant; MTX = Methotrexate; HCQ = hydroxychloroquine; LEF = leflunomide